Conference Reports for NATAP

62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back

Daclatasvir (DCV; BMS-790052), an NS5A Replication Complex Inhibitor, in Combination With Peginterferon Alfa-2b and Ribavirin in Japanese Treatment-Naïve and Nonresponder Patients With Chronic HCV Genotype 1 Infection       Reported by Jules Levin AASLD Nov 5-9 2011 SF   Suzuki F,1 Chayama K,2 Kawakami Y,2 Toyota J,3 Karino Y,3 Mochida S,4 Nagoshi S,4 Hayashi N,5 Takehara T,6 Ishikawa H,7 Miyagoshi H,7 Yang R,8 McPhee F,8 Hughes E,9 Kumada H1 1Toranomon Hospital, Tokyo, Japan; 2Hiroshima University, Hiroshima, Japan; 3Sapporo-Kousei General Hospital, Sapporo, Japan; 4Saitama Medical University, Saitama, Japan; 5Kansai-Rousai Hospital, Amagasaki, Japan; 6Osaka University, Osaka, Japan; 7Bristol-Myers KK, Tokyo, Japan; 8Bristol-Myers Squibb, Wallingford, CT; 9Bristol-Myers Squibb Research & Development, Princeton, NJ